0001209191-20-035129.txt : 20200608
0001209191-20-035129.hdr.sgml : 20200608
20200608193027
ACCESSION NUMBER: 0001209191-20-035129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200605
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Plat Francis
CENTRAL INDEX KEY: 0001772290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38899
FILM NUMBER: 20950535
MAIL ADDRESS:
STREET 1: C/O MILESTONE PHARMACEUTICALS, INC.
STREET 2: 1111 DR. FREDERIK-PHILIPS BLVD., STE 420
CITY: MONTR?AL
STATE: A8
ZIP: H4M 2X6
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001408443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
BUSINESS PHONE: (514) 336-0444
MAIL ADDRESS:
STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD
STREET 2: SUITE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-05
0
0001408443
Milestone Pharmaceuticals Inc.
MIST
0001772290
Plat Francis
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTR?AL
A8
H4M 2X6
QUEBEC, CANADA
0
1
0
0
Chief Medical Officer
Employee Stock Option (right to buy)
3.74
2020-06-05
4
A
0
35000
0.00
A
2030-06-05
Common Shares
35000
35000
D
The shares subject to this option shall vest in twenty-four (24) equal monthly installments commencing on July 5, 2020, subject to the recipient continuing to provide service to the Issuer through each such date.
/s/ Eric Popp, Attorney-in-Fact
2020-06-08